Our observation indicated that αPD1-mIL12mut2 primarily bound to CD8+T cells rather than tumor cells, whereas αEGFR-mIL12mut2 exhibited a stronger affinity to tumor cells over CD8+T cells. Here, CD8A is linked to neoplasm.